1548P A phase Ia/Ib, dose-escalation/expansion study of the MDM2–p53 antagonist BI 907828 in patients (pts) with advanced/metastatic sarcoma
Gounder M, Patel M, Yamamoto N, Bauer T, Laurie S, Perez-Pitarch A, Geng J, Cheng J, Lahmar M, Lorusso P. 1548P A phase Ia/Ib, dose-escalation/expansion study of the MDM2–p53 antagonist BI 907828 in patients (pts) with advanced/metastatic sarcoma. Annals Of Oncology 2021, 32: s1124-s1125. DOI: 10.1016/j.annonc.2021.08.878.Peer-Reviewed Original Research